News

Sight Sciences Announces the Closing of its $7MM Series B Financing Led by Hicks Equity Partners

September 22, 2016

Sight Sciences, Inc., a venture-backed, commercial-stage ophthalmic medical device company today announced it has closed a $7 million Series B round of financing. The round was led by Hicks Equity Partners, a leading private equity firm based in Dallas, Texas. All Series A investors participated in the oversubscribed Series B round, including Scientific Health Development (Series A Co-Lead), Allegro Investment Fund, and various other institutional and angel investors.

In The Media

April 23, 2024

Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting Read More

March 8, 2024

Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance Read More

February 23, 2024

Sight Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024 Read More

February 15, 2024

Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter Meeting Read More

January 24, 2024

Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital Read More

November 8, 2023

Sight Sciences Reports Third Quarter 2023 Financial Results and Withdraws Guidance for Full Year 2023 Read More

October 25, 2023

Sight Sciences to Report Third Quarter 2023 Financial Results on November 7, 2023 Read More

October 3, 2023

Sight Sciences Announces New, Large-Scale MIGS Data from 41st Congress of ESCRS Demonstrating TCOR™ Using OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma Read More

September 11, 2023

Sight Sciences Provides Revenue Guidance for the Third Quarter of 2023 and Updates Revenue Guidance for Full Year 2023 Read More

September 11, 2023

Sight Sciences Appoints Matt Link as Chief Commercial Officer Read More

Want to speak to one of our representatives?

Contact Us